CDKN2A and head and neck squamous cell carcinoma: Among all HNSCC cases analyzed, 17.5% were HPV+/p16+ (Figure 1C); 39.2, 9.6, and 14.7% of OPSCC, OCSCC and LASCC cases, respectively, were HPV+/p16+.